New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 8, 2014
07:33 EDTTKMRTekmira volatility expected to move on FDA modification of TKM-Ebola
Tekmira volatility is expected to move after announcing that the FDA verbally confirmed they have modified the full clinical hold placed on the TKM-Ebola to a partial clinical hold. August call option implied volatility is at 133, September is at 110, December is at 94, March is at 98; compared to its 15-week average of 99 according to Track Data, suggesting large near term price movement.
News For TKMR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 25, 2015
13:57 EDTTKMRUK nurse make full recovery from Ebola, WSJ says
Subscribe for More Information
January 23, 2015
10:07 EDTTKMRHigh option volume stocks
High option volume stocks: CE TSM RYAM NOC SNE FXCM LBTYA TKMR LF STT
January 22, 2015
16:41 EDTTKMRFalcon Edge Capital reports 9/9% passive stake in Tekmira
Subscribe for More Information
09:54 EDTTKMRTekmira mentioned cautiously by TheStreetSweeper
Subscribe for More Information
January 21, 2015
08:34 EDTTKMRTekmira initiates Phase I clinical trial of TKM-HBV
Subscribe for More Information
January 20, 2015
17:09 EDTTKMRRA Capital reports 9.9% passive stake in Tekmira
Subscribe for More Information
January 19, 2015
12:06 EDTTKMRNeurovive: Merger between Oncore and Tekmira includes NVP018 development
Subscribe for More Information
January 13, 2015
10:00 EDTTKMROn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:07 EDTTKMRTekmira price target raised to $35 from $25 at RBC Capital
Subscribe for More Information
07:09 EDTTKMRTekmira upgraded to Outperform from Market Perform at Leerink
Leerink upgraded Tekmira to Outperform with a $30 price target citing the company's merger with OnCore.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use